BridgeBio Pharma (BBIO) Restructuring Costs (2022 - 2025)
BridgeBio Pharma (BBIO) reported Restructuring Costs of $11.13 million for Q4 2025, up 137.2% from $4.69 million a year earlier and up 25.9% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Restructuring Costs (2022 - 2025) Analysis & Trends
For FY2025, BridgeBio Pharma posted Restructuring Costs of $21.35 million, up 36.8% from FY2024.
- Restructuring Costs has a three-year compound annual growth rate of -21.3% (FY2022 to FY2025).
- By year, Restructuring Costs came in at $15.61 million in FY2024 (+96.9%), $7.93 million in FY2023 (-81.9%) and $43.77 million in FY2022.
- The Q4 2025 figure ranks as the highest quarterly Restructuring Costs since Q1 2022.
- Year over year, Restructuring Costs gained in four of the last seven quarters, with growth averaging 82.6%.
- The high point for year-over-year Restructuring Costs in five years was Q4 2024 (growth of 522.4%); the low point was Q3 2023 (a decline of 94.6%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $8.84 million (Q3 2025), $805,000 (Q2 2025) and $570,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn |
| 10 | BridgeBio Pharma | 13.20 Bn | 10.31 Bn | 228.63 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 11.13 Mn |
| Sep 30, 2025 | 8.84 Mn |
| Jun 30, 2025 | 805,000.00 |
| Mar 31, 2025 | 570,000.00 |
| Dec 31, 2024 | 4.69 Mn |
| Sep 30, 2024 | 4.62 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | 3.40 Mn |
| Dec 31, 2023 | 754,000.00 |
| Sep 30, 2023 | 272,000.00 |
| Jun 30, 2023 | 3.53 Mn |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 7.69 Mn |
| Sep 30, 2022 | 5.02 Mn |
| Jun 30, 2022 | 8.40 Mn |
| Mar 31, 2022 | 22.66 Mn |
API Access
BridgeBio Pharma Restructuring Costs API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "restructuring-costs", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=restructuring-costs&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();